On December 10, Laura Rich will participate on a panel at the FDLI Enforcement, Litigation, and Compliance Conference titled, “MoCRA Year Two: What’s New, What’s Not, and What Now?” The session will focus on the regulatory implications of the Modernization of Cosmetics Regulation Act (MoCRA), enacted in 2022. Key topics include:
- FDA’s Continued Rollout of MoCRA
- Facility Registration & Product Listing: Insights from the first mandatory deadlines
- FDA's Proposed GMPs for Cosmetics
- Regulatory Preparedness: Best practices for managing records and data on adverse events, and possible recalls
- Inspection Readiness: Guidance on preparing for FDA inspections and understanding enforcement priorities
To learn more about the FDLI Enforcement, Litigation, and Compliance Conference, please click here.